Published in Arch Otorhinolaryngol on November 30, 1975
[The cumulogram for the sinusoidal rotatory test (author's transl)]. Arch Otorhinolaryngol (1979) 0.85
[Narrow nystagmus writing and hypoxemia of the central vestibular system (author's transl)]. Arch Otorhinolaryngol (1978) 0.78
[Computation of vestibular gain from single fast nystagmus phases (sinusoidal rotatory test) (author's transl)]. Arch Otorhinolaryngol (1979) 0.78
[Investigation of the influence of vigilance on the nystagmic reaction (author's transl)]. Arch Otorhinolaryngol (1982) 0.75
The correlation between the speed of the eye in the slow phase of nystagmus and vestibular stimulus. Acta Otolaryngol (1955) 0.99
Quantitative parameters in nystagmography. II. Nystagmus amplitude. ORL J Otorhinolaryngol Relat Spec (1974) 0.86
An electrical method for registration and analysis of the movements of the eyes in nystagmus. Acta Otolaryngol (1955) 0.86
[Automatic interpretation of electronystagmograms (author's transl)]. Biomed Tech (Berl) (1975) 0.85
Some observations on culmination and directional preponderance of the poststimulatory nystagmus. Laryngoscope (1962) 0.85
[The electro-nystagmometer--a new aid in quantitative vestibulometry]. Z Laryngol Rhinol Otol (1972) 0.84
Frequency meter for nystagmus analysis. Acta Otolaryngol (1962) 0.84
Quantitative parameters in nystagmography. I. The velocity of the slow phase. ORL J Otorhinolaryngol Relat Spec (1974) 0.84
[The automatic measurement of the rate of slow jerk of nystagmus. Equipment. Value for the study of reflectivity and nystagmus threshold]. Rev Laryngol Otol Rhinol (Bord) (1970) 0.83
Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J (1996) 6.66
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (2005) 4.91
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res (2007) 4.41
Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature (1997) 4.03
Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol (1997) 2.81
FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J (2000) 2.25
Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature (1996) 2.24
Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene (2000) 2.07
Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med (1992) 2.05
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod (2006) 2.03
[Recommendations for management of dyslipidemia in 2014]. Rev Med Suisse (2014) 2.02
B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med (2000) 2.02
Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol (1999) 1.76
Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost (2005) 1.72
White-coat hypertension--to treat or not to treat: a clinical dilemma. Arch Intern Med (2001) 1.70
A medical report from the stone age? Lancet (1999) 1.70
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood (1998) 1.61
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol (1994) 1.58
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58
Cough and ACE inhibitors. Arch Intern Med (1992) 1.52
Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol (2001) 1.51
Nature and rate of vascular refilling during hemodialysis and ultrafiltration. Kidney Int (1992) 1.46
Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod (2000) 1.44
Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med (1993) 1.44
Diazoxide--an effective vasodilator in accelerated hypertension. Am Heart J (1974) 1.41
Decreased nociceptive sensitivity: a biological risk marker for opiate dependence? Addiction (1997) 1.40
The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results. Radiat Res (2007) 1.37
Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review. Hum Reprod Update (2003) 1.34
Dendritic cell subsets and the regulation of Th1/Th2 responses. Semin Immunol (2001) 1.34
Signal recognition particle-dependent protein targeting, universal to all kingdoms of life. Rev Physiol Biochem Pharmacol (2002) 1.33
Crystal structures of Escherichia coli aspartate aminotransferase in two conformations. Comparison of an unliganded open and two liganded closed forms. J Mol Biol (1994) 1.32
Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo. J Leukoc Biol (1999) 1.30
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int Immunol (2000) 1.28
Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population. J Natl Cancer Inst (1992) 1.26
Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol (1990) 1.26
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol (1998) 1.22
Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor. Mol Cell Biol (1999) 1.21
Developmental fate of ovoid oocytes. Hum Reprod (2007) 1.18
Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension. Am J Cardiol (1987) 1.15
Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy. Biochemistry (1999) 1.14
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: study of errors in dosimetry. Radiat Res (2007) 1.13
Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells. Eur J Immunol (1998) 1.13
Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood (1998) 1.12
Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn (1997) 1.11
Embryo fragmentation in vitro and its impact on treatment and pregnancy outcome. Fertil Steril (2001) 1.11
Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett (2000) 1.10
Graft-vs-host reaction limited to a class II MHC difference results in a selective deficiency in L3T4+ but not in Lyt-2+ T helper cell function. J Immunol (1987) 1.08
Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med (1998) 1.07
Relative timing of inspiration and expiration affects respiratory sinus arrhythmia. Clin Exp Pharmacol Physiol (2000) 1.06
Insurance premium reductions. A motivating factor in long-term hypertensive treatment. JAMA (1984) 1.06
Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo. J Immunol (1990) 1.06
Induction of AP-2alpha expression by adenoviral infection involves inactivation of the AP-2rep transcriptional corepressor CtBP1. J Biol Chem (2001) 1.04
Crystal structure of phosphoserine aminotransferase from Escherichia coli at 2.3 A resolution: comparison of the unligated enzyme and a complex with alpha-methyl-l-glutamate. J Mol Biol (1999) 1.04
The genomic structure of the human AP-2 transcription factor. Nucleic Acids Res (1994) 1.04
Factors determining the frequency of plasmid cointegrate formation mediated by insertion sequence IS3 from Escherichia coli. Mol Gen Genet (1991) 1.04
Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up. J Laryngol Otol (2008) 1.03
Molecular mapping of idiotopes of anti-arsonate antibodies. J Immunol (1986) 1.02
Neurocan is dispensable for brain development. Mol Cell Biol (2001) 1.02
Nonspecific suppression of tumor growth by an immune reaction to Listeria monocytogenes. J Natl Cancer Inst (1974) 1.01
Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation (1991) 1.01
Evidence for a differential functional regulation of the two beta(3)-integrins alpha(V)beta(3) and alpha(IIb)beta(3). Exp Cell Res (2006) 1.01
Major depression and cardiac autonomic control. Biol Psychiatry (1997) 1.00
Idiotypic analysis of polyclonal and monoclonal anti-p-azophenylarsonate antibodies of BALB/c mice expressing the major cross-reactive idiotype of the A/J strain. J Immunol (1985) 0.98
Idiotypic manipulation in mice: BALB/c mice can express the crossreactive idiotype of A/J mice. Proc Natl Acad Sci U S A (1983) 0.98
Embryonic lethality caused by apoptosis during gastrulation in mice lacking the gene of the ADP-ribosylation factor-related protein 1. Mol Cell Biol (2002) 0.98
"Cost containment" in the management of hypertension. Ann Intern Med (1987) 0.98
[Postcommotional syndrome in electronystagmogram of penduling test (author's transl)]. Arch Otorhinolaryngol (1977) 0.98
Evaluating marrow margins for resection of osteosarcoma. A modern approach. Clin Orthop Relat Res (1999) 0.98
Evidence for a role of translational frameshifting in the expression of transposition activity of the bacterial insertion element IS1. Gene (1990) 0.97
Immunoglobulin isotype regulation by antigen-presenting cells in vivo. Eur J Immunol (1994) 0.97
In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers. J Pathol (1999) 0.96
Group culture of human zygotes is superior to individual culture in terms of blastulation, implantation and life birth. Reprod Biomed Online (2010) 0.96
Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients. Angiology (1981) 0.95
Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung. Clin Exp Allergy (2004) 0.95
Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. J Immunol (1999) 0.94
Planar embryos have poor prognosis in terms of blastocyst formation and implantation. Reprod Biomed Online (2012) 0.94
LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. Biochem J (2001) 0.94
Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc Pathol (2001) 0.94
Elective transfer of embryos selected on the basis of first polar body morphology is associated with increased rates of implantation and pregnancy. Fertil Steril (1999) 0.93
Devices used for self-measurement of blood pressure. Revised statement of the National High Blood Pressure Education Program. Arch Intern Med (1985) 0.93
Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity. Int J Cancer (1998) 0.93
The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. Transplant Proc (2004) 0.92
Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior. Oncogene (2011) 0.92
Characterization and expression pattern of the novel MIA homolog TANGO. Gene Expr Patterns (2004) 0.92
Responses to captopril and hydrochlorothiazide in black patients with hypertension. Clin Pharmacol Ther (1982) 0.91
Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect Immun (1998) 0.91
Activation of somatostatin receptor II expression by transcription factors MIBP1 and SEF-2 in the murine brain. Mol Cell Biol (1999) 0.91
[Central nystagmus writing during the pendular test. Findings on post-punctural symptoms after lumbar puncture (author's transl)]. Arch Otorhinolaryngol (1979) 0.91
Immunohistowax processing, a new fixation and embedding method for light microscopy, which preserves antigen immunoreactivity and morphological structures: visualisation of dendritic cells in peripheral organs. J Clin Pathol (2000) 0.91
Enhanced cartilage regeneration in MIA/CD-RAP deficient mice. Cell Death Dis (2010) 0.91
[Pendular test and ENG in rabbits (author's transl)]. Arch Otorhinolaryngol (1978) 0.91
Immune surveillance: both CD3+ CD4+ and CD3+ CD8+ T cells control in vivo growth of P815 mastocytoma. Int J Cancer (1990) 0.91
Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4. Clin Exp Immunol (1991) 0.90
Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line. Virology (1996) 0.90
Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med (1995) 0.89
Diuretics and beta-blockers: is there a risk for dyslipidemia? Am Heart J (2000) 0.89